newsfilter
← Latest News
Business Wire·

Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors

Delcath Systems, Inc. (NASDAQ:DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr.